{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:08:03Z","timestamp":1779340083850,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["1R56AI179226-01"],"award-info":[{"award-number":["1R56AI179226-01"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biomaterials.2026.124124","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:06:12Z","timestamp":1772899572000},"page":"124124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["HIV virion capturing liposomes for therapeutic vaccination"],"prefix":"10.1016","volume":"331","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8118-9137","authenticated-orcid":false,"given":"Ted Keunsil","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-552X","authenticated-orcid":false,"given":"Charles G.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Canziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6481-2986","authenticated-orcid":false,"given":"Heba","family":"Elkateb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8959-384X","authenticated-orcid":false,"given":"Derek","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos B.","family":"Smith III","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias K.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irwin","family":"Chaiken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2208-0174","authenticated-orcid":false,"given":"Peter","family":"Deak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124124_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trsl.2020.04.008","article-title":"Therapeutic vaccines for the treatment of HIV","volume":"223","author":"Chen","year":"2020","journal-title":"Transl. Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124124_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01804-22","article-title":"Structural and mechanistic bases of viral resistance to HIV-1 capsid inhibitor lenacapavir","volume":"13","author":"Bester","year":"2022","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124124_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/vaccines13030274","article-title":"Navigating the complexities of HIV vaccine development: lessons from the mosaico trial and next-generation development strategies","volume":"13","author":"Adepoju","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"697","key":"10.1016\/j.biomaterials.2026.124124_bib4","doi-asserted-by":"crossref","first-page":"eadf3309","DOI":"10.1126\/scitranslmed.adf3309","article-title":"A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses","volume":"15","author":"Cohen","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124124_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004955","article-title":"HIV latency is established directly and early in both resting and activated primary CD4 T cells","volume":"11","author":"Chavez","year":"2015","journal-title":"PLoS Pathog."},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124124_bib6","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1042\/BCJ20200495","article-title":"Identification of a glycan cluster in Gp120 essential for irreversible HIV-1 lytic inactivation by a lectin-based recombinantly engineered protein conjugate","volume":"477","author":"Parajuli","year":"2020","journal-title":"Biochem. J."},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124124_bib7","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1128\/JVI.00302-14","article-title":"Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication","volume":"88","author":"Abram","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","article-title":"Getting the \u201cKill\u201d into \u201cShock and kill\u201d: strategies to eliminate latent HIV","volume":"23","author":"Kim","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/s12879-017-2683-3","article-title":"Landscape review of current HIV \u201ckick and Kill\u201d cure research - some kicking, not enough killing","volume":"17","author":"Thorlund","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124124_bib10","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1038\/s41591-024-03247-5","article-title":"Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1\/2a trial","volume":"30","author":"Julg","year":"2024","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib11","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-025-57284-w","article-title":"Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial","volume":"16","author":"Bail\u00f3n","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124124_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1393974","article-title":"Delivering CRISPR to the HIV-1 reservoirs","volume":"15","author":"Gurrola","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biomaterials.2026.124124_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110368","article-title":"Eliminating the persistent HIV reservoir based on biomarker expression \u2013 how do we get there?","volume":"603","author":"Beliakova-Bethell","year":"2025","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/cells13010064","article-title":"Advancements in cell-based therapies for HIV cure","volume":"13","author":"Matsui","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biomaterials.2026.124124_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2022.933418","article-title":"How to break free: HIV-1 escapes from innovative therapeutic approaches","volume":"2","author":"Magro","year":"2022","journal-title":"Front. Virol."},{"key":"10.1016\/j.biomaterials.2026.124124_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1007037","article-title":"Editorial: HIV-1 genetic diversity, volume II","volume":"13","author":"Tee","year":"2022","journal-title":"Front. Microbiol."},{"issue":"7534","key":"10.1016\/j.biomaterials.2026.124124_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature14053","article-title":"Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations","volume":"517","author":"Deng","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01762-16","article-title":"Broadly neutralizing antibodies display potential for prevention of HIV-1 infection of mucosal tissue superior to that of nonneutralizing antibodies","volume":"91","author":"Cheeseman","year":"2017","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124124_bib19","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1128\/JVI.03380-13","article-title":"HLA-B\u221757 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice","volume":"88","author":"Salgado","year":"2014","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124124_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113530","article-title":"IL-15-Dependent immune crosstalk between natural killer cells and dendritic cells in HIV-1 elite controllers","volume":"42","author":"Hartana","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.biomaterials.2026.124124_bib21","doi-asserted-by":"crossref","unstructured":"Fritschi, C. J.; Anang, S.; Gong, Z.; Mohammadi, M.; Richard, J.; Bourassa, C.; Severino, K. T.; Richter, H.; Yang, D.; Chen, H.-C.; Chiu, T.-J.; Seaman, M. S.; Madani, N.; Abrams, C.; Finzi, A.; Hendrickson, W. A.; Sodroski, J. G.; Smith, A. B. Indoline CD4-Mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 120 (13), e2222073120. https:\/\/doi.org\/10.1073\/pnas.2222073120.","DOI":"10.1073\/pnas.2222073120"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124124_bib22","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.vaccine.2018.01.077","article-title":"Routing dependent immune responses after experimental R848-Adjuvated vaccination","volume":"36","author":"van Aalst","year":"2018","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124124_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/v13050735","article-title":"HIV-1 entry and membrane fusion inhibitors","volume":"13","author":"Xiao","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124124_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112556","article-title":"Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4+ T cells","volume":"42","author":"Itell","year":"2023","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124124_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/JLB.4A0721-365R","article-title":"Crosstalk between R848 and abortive HIV\u20101 RNA\u2010induced signaling enhances antiviral immunity","volume":"112","author":"Stunnenberg","year":"2022","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.20411\/pai.v1i1.125","article-title":"Interferons and HIV infection: the good, the bad, and the ugly","volume":"1","author":"Utay","year":"2016","journal-title":"Pathog Immun"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124124_bib27","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1158\/0008-5472.CAN-04-0138","article-title":"Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy","volume":"64","author":"van Broekhoven","year":"2004","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-3155-12-17","article-title":"A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7","volume":"12","author":"Fox","year":"2014","journal-title":"J. Nanobiotechnol."},{"issue":"37","key":"10.1016\/j.biomaterials.2026.124124_bib29","doi-asserted-by":"crossref","first-page":"22690","DOI":"10.1073\/pnas.2003968117","article-title":"Multivalent weak interactions enhance selectivity of interparticle binding","volume":"117","author":"Scheepers","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib30","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1038\/s41598-017-04268-6","article-title":"Determination of crucial immunogenic epitopes in major peanut allergy protein, ara H2, via novel nanoallergen platform","volume":"7","author":"Deak","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124124_bib31","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1021\/nn305663e","article-title":"A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes","volume":"7","author":"Stefanick","year":"2013","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/aid.1993.9.23","article-title":"A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope","volume":"9","author":"Jonak","year":"1993","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2001.1163","article-title":"Quantitative evaluation of HIV-1 coreceptor use in the GHOST(3) cell assay","volume":"291","author":"V\u00f6dr\u00f6s","year":"2001","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124124_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0324298","article-title":"Development and validation of a dynamic light scattering-based method for viral quantification: a straightforward protocol for a demanding task","volume":"20","author":"Navarro-Lopez","year":"2025","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124124_bib35","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1021\/acs.jmedchem.5b00073","article-title":"Peptide triazole inactivators of HIV-1 utilize a conserved two-cavity binding site at the junction of the inner and outer domains of env Gp120","volume":"58","author":"Aneja","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2026.124124_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.605307","article-title":"Surface plasmon resonance as a characterization tool for lipid nanoparticles used in drug delivery","volume":"8","author":"Chain","year":"2021","journal-title":"Front. Chem."},{"issue":"5993","key":"10.1016\/j.biomaterials.2026.124124_bib37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124124_bib38","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3390\/pharmaceutics13101696","article-title":"Liposomal resiquimod for enhanced immunotherapy of peritoneal metastases of colorectal cancer","volume":"13","author":"Pauli","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7335","key":"10.1016\/j.biomaterials.2026.124124_bib39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.biomaterials.2026.124124_bib40","doi-asserted-by":"crossref","first-page":"14637","DOI":"10.1073\/pnas.94.26.14637","article-title":"Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection","volume":"94","author":"Browning","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124124_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060989","article-title":"Effects of microparticle size and Fc density on macrophage phagocytosis","volume":"8","author":"Pacheco","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib42","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1479-5876-5-5","article-title":"Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells","volume":"5","author":"Ramakrishna","year":"2007","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124124_bib44","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood-2007-05-088435","article-title":"HIV-1\u2013Induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue Ex vivo","volume":"111","author":"Biancotto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2026.124124_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.749039","article-title":"Imaging flow cytometry and confocal immunofluorescence microscopy of virus-host cell interactions","volume":"11","author":"McClelland","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124124_bib46","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1529\/biophysj.103.038422","article-title":"Automatic and quantitative measurement of protein-protein colocalization in live cells","volume":"86","author":"Costes","year":"2004","journal-title":"Biophys. J."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124124_bib47","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.3390\/v6093400","article-title":"HIV-1 env-specific memory and germinal center B cells in C57BL\/6 mice","volume":"6","author":"Soldemo","year":"2014","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124124_bib48","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1172\/JCI130597","article-title":"RV397, RV411, and RV254 study groups. Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption","volume":"130","author":"Mitchell","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biomaterials.2026.124124_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01222","article-title":"What makes a pDC: recent advances in understanding plasmacytoid DC development and heterogeneity","volume":"10","author":"Musumeci","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124124_bib50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood-2003-12-4341","article-title":"HIV-1\u2013Specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both Interferon-\u03b3 and tumor necrosis Factor\u2013\u03b1","volume":"104","author":"Lichterfeld","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124124_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002442","article-title":"Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41","volume":"7","author":"Lai","year":"2011","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124124_bib52","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8+ T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124124_bib53","article-title":"HIV controllers: hope for a functional cure","volume":"16","author":"Deng","year":"2025","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124124_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/v15102055","article-title":"Higher HIV-1 env Gp120-Specific antibody-dependent cellular cytotoxicity (ADCC) activity is associated with lower levels of defective HIV-1 provirus","volume":"15","author":"Yucha","year":"2023","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124124_bib55","article-title":"Substantial uneven proliferation of CD4+ T cells during recovery from acute HIV infection is sufficient to explain the observed expanded clones in the HIV reservoir","volume":"8","author":"Tettamanti Boshier","year":"2022","journal-title":"J. Virus Erad."},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124124_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00415-17","article-title":"Dense array of spikes on HIV-1 virion particles","volume":"91","author":"Stano","year":"2017","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124124_bib57","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1097\/QAD.0000000000001982","article-title":"P24 revisited: a landscape review of antigen detection for early HIV diagnosis","volume":"32","author":"Gray","year":"2018","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124124_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.977","article-title":"Therapeutic strategies and promising vaccine for hepatitis C virus infection","volume":"11","author":"Adugna","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124124_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104528","article-title":"VE607 stabilizes SARS-CoV-2 spike in the \u201cRBD-up\u201d conformation and inhibits viral entry","volume":"25","author":"Ding","year":"2022","journal-title":"iScience"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124124_bib60","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1128\/JVI.00433-12","article-title":"A 3-O-Sulfated heparan sulfate binding peptide preferentially targets Herpes simplex virus 2-Infected cells","volume":"86","author":"Ali","year":"2012","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124124_bib61","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124124_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.617516","article-title":"Advances in humanized mouse models to improve understanding of HIV-1 pathogenesis and immune responses","volume":"11","author":"Gillgrass","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124124_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-11362-7","article-title":"Retrovirus-based pseudotyped virus neutralisation assays overestimate neutralising activity in sera from participants receiving integrase inhibitors","volume":"15","author":"McCormack","year":"2025","journal-title":"Sci. Rep."},{"issue":"45","key":"10.1016\/j.biomaterials.2026.124124_bib64","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1016\/j.vaccine.2017.09.052","article-title":"Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system","volume":"35","author":"Cheng","year":"2017","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124124_bib65","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00044-023-03092-0","article-title":"Pharmacophore variants of the macrocyclic peptide triazole inactivator of HIV-1 env","volume":"32","author":"Gupta","year":"2023","journal-title":"Med. Chem. Res."},{"issue":"Pt 3","key":"10.1016\/j.biomaterials.2026.124124_bib66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","article-title":"A guided tour into subcellular colocalization analysis in light microscopy","volume":"224","author":"Bolte","year":"2006","journal-title":"J. Microsc."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226001481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226001481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:22:09Z","timestamp":1779337329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226001481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":66,"alternative-id":["S0142961226001481"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124124","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV virion capturing liposomes for therapeutic vaccination","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"124124"}}